Novartis Transderm Scop Superiority Claim Disputed By Pharmacia In Petition

Pharmacia is requesting that FDA modify the physician package insert for Novartis' Transderm Scop motion sickness patch to remove a statement claiming superiority to OTC oral dimenhydrinate.